Adam Drapczuk
Vermogen: 61 315 $ op 30-06-2026
Vermogen: 61 315 $ op 30-06-2026
Adam E.
Drapczuk worked at West-Ward Pharmaceutical Corp.
from 2001 to 2011, serving as Finance Director from 2008 to 2011.
From 2011 to 2016, worked at Tris Pharma, Inc. as Finance Director & Controller.
In 2016, held the position of Chief Financial Officer & Vice President-Finance at Inpellis, Inc. Also in 2016, worked as Financial Controller at R-Pharm US LLC until 2020.
From 2021 to 2025, served as Chief Financial & Accounting Officer at NexGel, Inc., continuing in that role through 2026.
Education includes undergraduate studies at Susquehanna University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NEXGEL, INC. 1,33% | 03-06-2026 | 122.385 ( 1,33% ) | 61 315 $ | 30-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| NEXGEL, INC. | Comptroller/Controller/Auditor | 27-04-2026 |
| NEXGEL, INC. | Financieel Directeur/CFO | 31-12-2025 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Comptroller/Controller/Auditor | 01-04-2020 |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Financieel Directeur/CFO | 01-04-2016 |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Financieel Directeur/CFO | 01-02-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Susquehanna University
Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West-Ward Pharmaceutical Corp.
West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Provides generic prescription medication services | Health Technology |
NexGel, Inc.
NexGel, Inc. Chemicals: SpecialtyProcess Industries Manufactures hydrogel compounds | Process Industries |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau